NDC 80425-0139-01 - Ketorolac Tromethamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0139
- Requested NDC
- 80425-0139-01
- Package NDCs from labels
- 80425-0139-1, 80425-0139-3, 80425-0139-2, 80425-0139-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ketorolac Tromethamine - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0139-1 | Ketorolac Tromethamine | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 5 | |
| 80425-0139-2 | Ketorolac Tromethamine | 9 in 1 BOTTLE | TABLET, FILM COATED | 9 | 5 | |
| 80425-0139-3 | Ketorolac Tromethamine | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0139 | KETOROLAC TROMETHAMINE TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 3 package rows | 20250101_c1717245-cef3-b3d7-e053-2a95a90a1ac5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0139-1 | EA - Each | 80425-0139 | 70add81b-d8f5-4118-b5c1-05bf84165ade | 1 | 2023-06-06 |
| 80425-0139-2 | EA - Each | 80425-0139 | 0b665173-2504-4c55-b5a5-980fa83937b7 | 1 | 2023-06-06 |
| 80425-0139-3 | EA - Each | 80425-0139 | fcf73ba8-2e41-4714-89c3-f0dc2d794b1e | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Northwind Health Company, LLC | 08674066-7d4b-936d-e063-6394a90abbd7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Northwind Health Company, LLC | d17ed469-677b-4a2e-96a9-5cfd0f50ecd9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA074754 834022 4EVE5946BQ |
| ketorolac tromethamine | KETOROLAC TROMETHAMINE | ProPharma Distribution | 42dfd39e-53a3-e9ee-e063-6394a90ab51e | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| KETOROLAC TROMETHAMINE | KETOROLAC TROMETHAMINE | Medical Purchasing Solutions, LLC | 46434a32-b727-0c5b-e063-6394a90a0c48 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Redpharm Drug | 37453bcd-e34b-5902-e063-6294a90a0245 | 2025-12-13 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| ketorolac tromethamine | KETOROLAC TROMETHAMINE | Amici Pharma Inc. | 8b26240c-b72b-42a6-ab33-a1e38224fbe0 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | SOLA Pharmaceuticals, LLC | 2301a6a2-b88a-4c0d-bb6c-ad4a8af7da39 | 2025-12-08 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | SOLA Pharmaceuticals, LLC | b08a46f3-36c9-405d-a963-9739a5c87f9c | 2025-12-08 | Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Chartwell RX, LLC | 3855f527-fd6c-4f24-a4b4-cd47eec1193d | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| ketorolac tromethamine | KETOROLAC TROMETHAMINE | A-S Medication Solutions | d8e928ac-c1e7-4b7a-87cd-9d11e36d53c0 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | A-S Medication Solutions | 3321b610-1c9b-4314-adbb-a2e163234dec | 2025-11-18 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac tromethamine | KETOROLAC TROMETHAMINE | A-S Medication Solutions | 5e42914f-de71-4176-819b-9fa26a8bdce6 | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| KETOROLAC TROMETHAMINE | KETOROLAC TROMETHAMINE | Sandoz Inc | 79e29a86-1b44-4d95-8d84-5a2e8f23ddcf | 2025-10-27 | Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Sagent Pharmaceuticals | 62591551-a644-4b2c-a0de-982e906fabc3 | 2025-10-25 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Cardinal Health 107, LLC | 63b73913-246d-4e5b-bdc9-c202980d8777 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | A-S Medication Solutions | 49e04373-568d-48fa-ac1c-b7d6b493e777 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Proficient Rx LP | 38fc11a0-50d1-4ba5-8d46-331eb74a00d6 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 834022 4EVE5946BQ |
| KETOROLAC TROMETHAMINE | KETOROLAC TROMETHAMINE | Onesource Specialty Pharma Limited | 4596483b-990b-eaa4-e063-6394a90ac08f | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| KETOROLAC TROMETHAMINE | KETOROLAC TROMETHAMINE | Onesource Specialty Pharma Limited | 45966992-5af6-bf10-e063-6294a90af25b | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | 4EVE5946BQ |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Micro Labs Limited | 631c2c31-cd4f-4a17-85c6-be96746a753e | 2025-09-29 | Warnings, Adverse reactions | 4EVE5946BQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.